Clinical Trial Update: Comparison of Solifenacin and Oxybutynin in the Treatment of Overactive Bladder [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update comparing solifenacin to oxybutynin for overactive bladder; no trial results are provided in the snippet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder

Drugs mentioned

• Solifenacin (solifenacin)
• oxybutynin (oxybutynin)

Snippet

Sponsor: Adana Numune Training and Research Hospital | Conditions: Overactive Bladder | Phase 4 | Status: UNKNOWN